The effects of macro-algae supplementation on serum lipid, glycaemic control and anthropometric indices: A systematic review and meta-analysis of clinical trials

IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Endocrinology, Diabetes and Metabolism Pub Date : 2023-07-19 DOI:10.1002/edm2.439
Shahla Rezaei, Saeid Doaei, Reza Tabrizi, Saeed Ghobadi, Morteza Zare, Maryam Gholamalizadeh, Zohreh Mazloom
{"title":"The effects of macro-algae supplementation on serum lipid, glycaemic control and anthropometric indices: A systematic review and meta-analysis of clinical trials","authors":"Shahla Rezaei,&nbsp;Saeid Doaei,&nbsp;Reza Tabrizi,&nbsp;Saeed Ghobadi,&nbsp;Morteza Zare,&nbsp;Maryam Gholamalizadeh,&nbsp;Zohreh Mazloom","doi":"10.1002/edm2.439","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Macro-algae products have been shown to ameliorate the metabolic disorders state. Thus, highlighting their function as supplementary therapeutic agents can be a novel strategy for clinical therapies. This systematic review and meta-analysis of clinical trials aimed to summarize the effect of macro-algae consumption on serum lipid profile, glycaemic control and anthropometric factors.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In this systematic review and meta-analysis, a comprehensive search was performed for relevant studies published up to May 2023. The Cochran's <i>Q</i> test and <i>I</i>-square (<i>I</i><sup>2</sup>) tests were used to evaluate heterogeneity across the included studies. The meta-analysis was conducted using random-effects model (DerSimonian and Laird), and weighted mean difference (WMD) was considered as the pooled effect size.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Out of 8602 papers in the initial screening, eight clinical trials with a total of 438 participants were included into this meta-analysis. The results indicated that macro-algae supplementation significantly decreased serum levels of total cholesterol (TC) (WMD = −6.7 mg/dL; 95% CI: −12.59, −0.80; item = 0.026) and low-density lipoprotein cholesterol (LDL-c) (WMD = −8.25 mg/dL; 95% CI: −15.38, −1.12; <i>p</i>-value = .023). There was an increase in level of high-density lipoprotein cholesterol (HDL-c) (WMD = 0.48 mg/dL; 95% CI: −2.05, 3.01; <i>p</i>-value = .71) which was not statistically significant. Macro-algae supplementation reduced body mass index (BMI) (WMD = −0.28 kg/m<sup>2</sup>; 95% CI: −0.96, 0.41; <i>p</i>-value = .426), weight (WMD = −0.39 kg; 95% CI: −3.6, 2.83; <i>p</i>-value = .81), waist circumference (WC) (WMD = −0.52 cm; 95% CI: −2.71, 1.66; <i>p</i>-value = .64), fasting blood sugar (FBS) (WMD = −1.95 mg/dL; 95% CI: −5.19, 1.28; <i>p</i>-value = .24) and HbA1c (WMD = −0.02%; 95% CI: −0.14, 0.09; <i>p</i>-value = .66) in intervention group.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This meta-analysis indicated that macro-algae supplementation significantly decreased TC and LDL-c level. It can also increase HDL-c level and reduce anthropometric indices and glycaemic control factors.</p>\n </section>\n </div>","PeriodicalId":36522,"journal":{"name":"Endocrinology, Diabetes and Metabolism","volume":"6 5","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2023-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/edm2.439","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinology, Diabetes and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/edm2.439","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Macro-algae products have been shown to ameliorate the metabolic disorders state. Thus, highlighting their function as supplementary therapeutic agents can be a novel strategy for clinical therapies. This systematic review and meta-analysis of clinical trials aimed to summarize the effect of macro-algae consumption on serum lipid profile, glycaemic control and anthropometric factors.

Methods

In this systematic review and meta-analysis, a comprehensive search was performed for relevant studies published up to May 2023. The Cochran's Q test and I-square (I2) tests were used to evaluate heterogeneity across the included studies. The meta-analysis was conducted using random-effects model (DerSimonian and Laird), and weighted mean difference (WMD) was considered as the pooled effect size.

Results

Out of 8602 papers in the initial screening, eight clinical trials with a total of 438 participants were included into this meta-analysis. The results indicated that macro-algae supplementation significantly decreased serum levels of total cholesterol (TC) (WMD = −6.7 mg/dL; 95% CI: −12.59, −0.80; item = 0.026) and low-density lipoprotein cholesterol (LDL-c) (WMD = −8.25 mg/dL; 95% CI: −15.38, −1.12; p-value = .023). There was an increase in level of high-density lipoprotein cholesterol (HDL-c) (WMD = 0.48 mg/dL; 95% CI: −2.05, 3.01; p-value = .71) which was not statistically significant. Macro-algae supplementation reduced body mass index (BMI) (WMD = −0.28 kg/m2; 95% CI: −0.96, 0.41; p-value = .426), weight (WMD = −0.39 kg; 95% CI: −3.6, 2.83; p-value = .81), waist circumference (WC) (WMD = −0.52 cm; 95% CI: −2.71, 1.66; p-value = .64), fasting blood sugar (FBS) (WMD = −1.95 mg/dL; 95% CI: −5.19, 1.28; p-value = .24) and HbA1c (WMD = −0.02%; 95% CI: −0.14, 0.09; p-value = .66) in intervention group.

Conclusions

This meta-analysis indicated that macro-algae supplementation significantly decreased TC and LDL-c level. It can also increase HDL-c level and reduce anthropometric indices and glycaemic control factors.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巨藻补充对血脂、血糖控制和人体测量指标的影响:临床试验的系统回顾和荟萃分析
大型藻类产品已被证明可以改善代谢紊乱状态。因此,强调其作为辅助治疗剂的功能可能是临床治疗的新策略。本研究对临床试验进行系统回顾和荟萃分析,旨在总结巨藻食用对血脂、血糖控制和人体测量因子的影响。方法在本系统综述和荟萃分析中,对截至2023年5月发表的相关研究进行全面检索。采用Cochran’s Q检验和I-square (I2)检验来评估纳入研究的异质性。meta分析采用随机效应模型(DerSimonian and Laird),以加权平均差(weighted mean difference, WMD)作为合并效应大小。在最初筛选的8602篇论文中,8项临床试验共438名参与者被纳入本荟萃分析。结果表明:饲粮中添加巨藻可显著降低血清总胆固醇(TC)水平(WMD = - 6.7 mg/dL;95% ci:−12.59,−0.80;item = 0.026)和低密度脂蛋白胆固醇(LDL-c) (WMD =−8.25 mg/dL;95% ci:−15.38,−1.12;p值= 0.023)。高密度脂蛋白胆固醇(HDL-c)水平升高(WMD = 0.48 mg/dL;95% ci:−2.05,3.01;p值= .71),差异无统计学意义。添加巨藻可降低体重指数(BMI) (WMD = - 0.28 kg/m2;95% ci:−0.96,0.41;p值= .426),体重(WMD = - 0.39 kg;95% ci:−3.6,2.83;p值= .81),腰围(WC) (WMD = - 0.52 cm;95% ci:−2.71,1.66;p值= 0.64),空腹血糖(FBS) (WMD =−1.95 mg/dL;95% ci:−5.19,1.28;p值= 0.24)和糖化血红蛋白(WMD = - 0.02%;95% ci:−0.14,0.09;p值= 0.66)。结论本荟萃分析表明,巨藻补充剂可显著降低TC和LDL-c水平。它还能提高HDL-c水平,降低人体测量指标和血糖控制因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and Metabolism Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.00
自引率
0.00%
发文量
66
审稿时长
6 weeks
期刊最新文献
Trends in Alzheimer's-Related Mortality Among Type 2 Diabetes Patients in the United States: 1999–2019 Association Between TyG-BMI Index and Hyperuricemia in Adult Women Issue Information The Role of Serum Free Fatty Acids in Endothelium-Dependent Microvascular Function Association of Albumin-To-Creatinine Ratio With Diabetic Retinopathy Among US Adults (NHANES 2009–2016)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1